The current state-of-the-art in cancer diagnosis and treatment is not ideal, diagnostic tests are accurate but invasive, and treatments are one-size fits-all instead of being personalized. Recently, miRNAs have garnered significant attention as cancer biomarkers, owing to their ease of access (circulating miRNA in the blood) and stability. There have been many studies showing the effectiveness of miRNA data in diagnosing specific cancer types, but few studies explore the role of miRNA in predicting treatment outcome.